Onkologie, Hämatologie - Daten und Informationen
SitemapSitemap  


7.1-7.4 Supportive Therapie mit Blut und Blutkomponenten (Erythrozyten, Thrombozyten, Granulozyten, gefrorenes Frischplasma): Literatur

Autor/en: N. Ahrens, A. Salama
Letzte Änderung: 25.01.2006
  • Allain JP.
    Transfusion risks of yesterday and of today.
    Transfus Clin Biol 2003;10:1-5. PM:12668180
    [Medline]


  • Andreu G, Morel P, Forestier F, Debeir J, Rebibo D, Janvier G, Herve P.
    Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998.
    Transfusion 2002;42:1356-1364. PM:12423521
    [Medline]


  • Boshkov LK.
    Transfusion-associated acute lung injury (TRALI): an evolving understanding of the role of anti-leukocyte antibodies.
    Vox Sang 2002;83:299-303. PM:12617157
    [Medline]


  • Brand A.
    Immunological aspects of blood transfusions.
    Transpl Immunol 2002;10:183-190. PM:12216948
    [Medline]


  • Daniels G, Poole J, de Silva M, Callaghan T, MacLennan S, Smith N.
    The clinical significance of blood group antibodies.
    Transfus Med 2002;12:287-295. PM:12383334
    [Medline]


  • Dodd RY.
    Bacterial contamination and transfusion safety: experience in the United States.
    Transfus Clin Biol 2003;10:6-9. PM:12668181
    [Medline]


  • Flegel WA, Wagner FF, Muller TH, Gassner C.
    Rh phenotype prediction by DNA typing and its application to practice.
    Transfus Med 1998;8:281-302. PM:9881423
    [Medline]


  • Goodnough LT.
    Risks of blood transfusion.
    Crit Care Med 2003;31:678-686. PM:14724466
    [Medline]


  • Graul A, Heiden M, Gräf K, Keller-Stanislawski B.
    Hämovigilanz in Deutschland - Berichte an das Paul-Ehrlich-Institut über Verdachtsfälle von Transfusionsreaktionen im Beobachtungszeitraum Januar 1995 bis Dezember 2002.
    Transfus Med Hemother 2003;30:232-238.


  • Heddle NM.
    Pathophysiology of febrile nonhemolytic transfusion reactions.
    Curr Opin Hematol 1999;6:420-426. PM:10546797
    [Medline]


  • Hübel K, Engert A.
    Granulocyte transfusion therapy for treatment of infections after cytotoxic chemotherapy.
    Onkologie 2003;26:73-79. PM:12624522
    [Medline]


  • Iserson KV, Huestis DW.
    Blood warming: current applications and techniques.
    Transfusion 1991;31:558-571. PM:1853451
    [Medline]


  • Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten.
    Köln: Deutscher Ärzte-Verlag 2003.


  • Linden JV, Wagner K, Voytovich AE, Sheehan J.
    Transfusion errors in New York State: an analysis of 10 years' experience.
    Transfusion 2000;40:1207-1213. PM:11061857
    [Medline]


  • Mollison PL, Engelfriet CP, Contreras M, Jones J.
    Blood transfusion in clinical medicine, 10 edn.
    Oxford: Blackwell Science 1997.


  • Norfolk DR, Ancliffe PJ, Contreras M, Hunt BJ, Machin SJ, Murphy WG, Williamson LM.
    Consensus Conference on Platelet Transfusion, Royal College of Physicians of Edinburgh, 27-28 November 1997. Synopsis of background papers.
    Br J Haematol 1998;101:609-617. PM:9674730
    [Medline]


  • Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie).
    Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 2000; 43: 555-589. Neuformulierung 2003: Dt Ärzteblatt 2003;101:299.


  • Rouger P, Noizat-Pirenne F, Le Pennec PY.
    Haemovigilance and transfusion safety in France.
    Vox Sang 2000;78:287-289. PM:10938971
    [Medline]


  • Rowe AW.
    Cryopreservation of red cells by freezing and vitrification - some recollections and predictions.
    Infus Ther Transfus Med 2002;29:25-30.


  • Schiffer CA, Anderson KC, Bennett CL, Bernstein S, Elting LS, Goldsmith M, Goldstein M, Hume H, McCullough JJ, McIntyre RE, Powell BL, Rainey JM, Rowley SD, Rebulla P, Troner MB, Wagnon AH.
    Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology.
    J Clin Oncol 2001;19:1519-1538. PM:11230498
    [Medline]


  • Schroeder ML.
    Transfusion-associated graft-versus-host disease.
    Br J Haematol 2002;117:275-287. PM:11972509
    [Medline]


  • Silliman CC, Boshkov LK, Mehdizadehkashi Z, Elzi DJ, Dickey WO, Podlosky L, Clarke G, Ambruso DR.
    Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors.
    Blood 2003;101:454-462. PM:12393667
    [Medline]


  • Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M.
    Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.
    Thromb Haemost 2001;86:1327-1330. PM:11816725
    [Medline]


  • Vamvakas EC, Blajchman MA.
    Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?
    Blood 2001;97:1180-1195. PM:11222359
    [Medline]


  • Winters JL, Pineda AA, Gorden LD, Bryant SC, Melton LJ 3rd, Vamvakas EC, Moore SB.
    RBC alloantibody specificity and antigen potency in Olmsted County, Minnesota. Transfusion 2001;41:1413-1420. PM:11724988
    [Medline]


Bei ONKODIN publiziert in Kooperation mit "Deutscher Ärzte-Verlag"
Deutscher Ärzte-Verlag  Deutscher Ärzte-Verlag
[Mehr]